Table 1

     Table. Drugs for Gastroesophageal Cancer

 

 

Product

 

Class

 

Target

 

Clinical Stage

 

Manufacturer

 

ABX-EGF

 

Antibody

 

EGFR

 

Phase I

Amgen and Abgenix

 

G17DT

 

Hormone

 

G-17

 

Phase II

Aphton and Aventis

 

Pegamotecan

 

Topoisomerase

 

Topoisomerase I

 

Phase II

 

Enzon

 

Tezacitabine

 

Nucleoside analogue

 

DNA

 

Phase II

 

Chiron